Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis

Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Multiple sclerosis and related disorders 2022-01, Vol.57, p.103431-103431, Article 103431
Hauptverfasser: Spiezia, Antonio Luca, Cerbone, Vincenza, Molinari, Eduardo Alberto, Capasso, Nicola, Lanzillo, Roberta, Carotenuto, Antonio, Petracca, Maria, Novarella, Federica, Covelli, Bianca, Scalia, Giulia, Brescia Morra, Vincenzo, Moccia, Marcello
Format: Artikel
Sprache:eng
Schlagworte:
Cladribine
Cladribine - therapeutic use
Humans
Immunoglobulin
Immunoglobulins
Lymphocytes
Multiple sclerosis
Multiple Sclerosis - drug therapy
Neutrophils
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 103431
container_issue
container_start_page 103431
container_title Multiple sclerosis and related disorders
container_volume 57
creator Spiezia, Antonio Luca
Cerbone, Vincenza
Molinari, Eduardo Alberto
Capasso, Nicola
Lanzillo, Roberta
Carotenuto, Antonio
Petracca, Maria
Novarella, Federica
Covelli, Bianca
Scalia, Giulia
Brescia Morra, Vincenzo
Moccia, Marcello
description
doi_str_mv 10.1016/j.msard.2021.103431
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2607579022</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2211034821006970</els_id><sourcerecordid>2607579022</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-a878d39373cfac61f4bb25fcea25365076ea728bfc41c1def3bd5143662525203</originalsourceid><addsrcrecordid>eNp9kEtvGyEQgFGVKo4S_4JI1R5z6Lo8FnZ96CGy0odkqZf0jFiYtbGA3QJbyf--OHZ9DBxAwzczzIfQI8Ergon4clj5pKJZUUxJibCGkQ_ojlJCasy4uLnem26BlikdcFmCk0aQW7Qo0ZZ0vL1DbrNXYQepsqFyRz_tR33MkD5XAeYcx2lvXapUMJX1fg7jzo397Gx444-gYk0q7ZSJtrcBqhxBZQ8hn5797LKdHFRJO4hjsukBfRyUS7C8nPfo97eX182Pevvr-8_N87bWjK9zrbq2M2zNWqYHpQUZmr6nfNCgKGeC41aAamnXD7ohmhgYWG_KZEwIysvG7B49netOcfwzQ8rS26TBORVgnJOkAre8XWNKC8rOqC4_TBEGOUXrVTxKguXJtDzIN9PyZFqeTZesT5cGc-_BXHP-ey3A1zMAZcy_FqJM2kLQYGwEnaUZ7bsN_gFG15F0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2607579022</pqid></control><display><type>article</type><title>Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Spiezia, Antonio Luca ; Cerbone, Vincenza ; Molinari, Eduardo Alberto ; Capasso, Nicola ; Lanzillo, Roberta ; Carotenuto, Antonio ; Petracca, Maria ; Novarella, Federica ; Covelli, Bianca ; Scalia, Giulia ; Brescia Morra, Vincenzo ; Moccia, Marcello</creator><creatorcontrib>Spiezia, Antonio Luca ; Cerbone, Vincenza ; Molinari, Eduardo Alberto ; Capasso, Nicola ; Lanzillo, Roberta ; Carotenuto, Antonio ; Petracca, Maria ; Novarella, Federica ; Covelli, Bianca ; Scalia, Giulia ; Brescia Morra, Vincenzo ; Moccia, Marcello</creatorcontrib><identifier>ISSN: 2211-0348</identifier><identifier>EISSN: 2211-0356</identifier><identifier>DOI: 10.1016/j.msard.2021.103431</identifier><identifier>PMID: 34871857</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Cladribine ; Cladribine - therapeutic use ; Humans ; Immunoglobulin ; Immunoglobulins ; Lymphocytes ; Multiple sclerosis ; Multiple Sclerosis - drug therapy ; Neutrophils</subject><ispartof>Multiple sclerosis and related disorders, 2022-01, Vol.57, p.103431-103431, Article 103431</ispartof><rights>2021 Elsevier B.V.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-a878d39373cfac61f4bb25fcea25365076ea728bfc41c1def3bd5143662525203</citedby><cites>FETCH-LOGICAL-c359t-a878d39373cfac61f4bb25fcea25365076ea728bfc41c1def3bd5143662525203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34871857$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Spiezia, Antonio Luca</creatorcontrib><creatorcontrib>Cerbone, Vincenza</creatorcontrib><creatorcontrib>Molinari, Eduardo Alberto</creatorcontrib><creatorcontrib>Capasso, Nicola</creatorcontrib><creatorcontrib>Lanzillo, Roberta</creatorcontrib><creatorcontrib>Carotenuto, Antonio</creatorcontrib><creatorcontrib>Petracca, Maria</creatorcontrib><creatorcontrib>Novarella, Federica</creatorcontrib><creatorcontrib>Covelli, Bianca</creatorcontrib><creatorcontrib>Scalia, Giulia</creatorcontrib><creatorcontrib>Brescia Morra, Vincenzo</creatorcontrib><creatorcontrib>Moccia, Marcello</creatorcontrib><title>Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis</title><title>Multiple sclerosis and related disorders</title><addtitle>Mult Scler Relat Disord</addtitle><subject>Cladribine</subject><subject>Cladribine - therapeutic use</subject><subject>Humans</subject><subject>Immunoglobulin</subject><subject>Immunoglobulins</subject><subject>Lymphocytes</subject><subject>Multiple sclerosis</subject><subject>Multiple Sclerosis - drug therapy</subject><subject>Neutrophils</subject><issn>2211-0348</issn><issn>2211-0356</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtvGyEQgFGVKo4S_4JI1R5z6Lo8FnZ96CGy0odkqZf0jFiYtbGA3QJbyf--OHZ9DBxAwzczzIfQI8Ergon4clj5pKJZUUxJibCGkQ_ojlJCasy4uLnem26BlikdcFmCk0aQW7Qo0ZZ0vL1DbrNXYQepsqFyRz_tR33MkD5XAeYcx2lvXapUMJX1fg7jzo397Gx444-gYk0q7ZSJtrcBqhxBZQ8hn5797LKdHFRJO4hjsukBfRyUS7C8nPfo97eX182Pevvr-8_N87bWjK9zrbq2M2zNWqYHpQUZmr6nfNCgKGeC41aAamnXD7ohmhgYWG_KZEwIysvG7B49netOcfwzQ8rS26TBORVgnJOkAre8XWNKC8rOqC4_TBEGOUXrVTxKguXJtDzIN9PyZFqeTZesT5cGc-_BXHP-ey3A1zMAZcy_FqJM2kLQYGwEnaUZ7bsN_gFG15F0</recordid><startdate>202201</startdate><enddate>202201</enddate><creator>Spiezia, Antonio Luca</creator><creator>Cerbone, Vincenza</creator><creator>Molinari, Eduardo Alberto</creator><creator>Capasso, Nicola</creator><creator>Lanzillo, Roberta</creator><creator>Carotenuto, Antonio</creator><creator>Petracca, Maria</creator><creator>Novarella, Federica</creator><creator>Covelli, Bianca</creator><creator>Scalia, Giulia</creator><creator>Brescia Morra, Vincenzo</creator><creator>Moccia, Marcello</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202201</creationdate><title>Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis</title><author>Spiezia, Antonio Luca ; Cerbone, Vincenza ; Molinari, Eduardo Alberto ; Capasso, Nicola ; Lanzillo, Roberta ; Carotenuto, Antonio ; Petracca, Maria ; Novarella, Federica ; Covelli, Bianca ; Scalia, Giulia ; Brescia Morra, Vincenzo ; Moccia, Marcello</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-a878d39373cfac61f4bb25fcea25365076ea728bfc41c1def3bd5143662525203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Cladribine</topic><topic>Cladribine - therapeutic use</topic><topic>Humans</topic><topic>Immunoglobulin</topic><topic>Immunoglobulins</topic><topic>Lymphocytes</topic><topic>Multiple sclerosis</topic><topic>Multiple Sclerosis - drug therapy</topic><topic>Neutrophils</topic><toplevel>online_resources</toplevel><creatorcontrib>Spiezia, Antonio Luca</creatorcontrib><creatorcontrib>Cerbone, Vincenza</creatorcontrib><creatorcontrib>Molinari, Eduardo Alberto</creatorcontrib><creatorcontrib>Capasso, Nicola</creatorcontrib><creatorcontrib>Lanzillo, Roberta</creatorcontrib><creatorcontrib>Carotenuto, Antonio</creatorcontrib><creatorcontrib>Petracca, Maria</creatorcontrib><creatorcontrib>Novarella, Federica</creatorcontrib><creatorcontrib>Covelli, Bianca</creatorcontrib><creatorcontrib>Scalia, Giulia</creatorcontrib><creatorcontrib>Brescia Morra, Vincenzo</creatorcontrib><creatorcontrib>Moccia, Marcello</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Multiple sclerosis and related disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spiezia, Antonio Luca</au><au>Cerbone, Vincenza</au><au>Molinari, Eduardo Alberto</au><au>Capasso, Nicola</au><au>Lanzillo, Roberta</au><au>Carotenuto, Antonio</au><au>Petracca, Maria</au><au>Novarella, Federica</au><au>Covelli, Bianca</au><au>Scalia, Giulia</au><au>Brescia Morra, Vincenzo</au><au>Moccia, Marcello</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis</atitle><jtitle>Multiple sclerosis and related disorders</jtitle><addtitle>Mult Scler Relat Disord</addtitle><date>2022-01</date><risdate>2022</risdate><volume>57</volume><spage>103431</spage><epage>103431</epage><pages>103431-103431</pages><artnum>103431</artnum><issn>2211-0348</issn><eissn>2211-0356</eissn><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>34871857</pmid><doi>10.1016/j.msard.2021.103431</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2211-0348
ispartof Multiple sclerosis and related disorders, 2022-01, Vol.57, p.103431-103431, Article 103431
issn 2211-0348
2211-0356
language eng
recordid cdi_proquest_miscellaneous_2607579022
source MEDLINE; Alma/SFX Local Collection
subjects Cladribine
Cladribine - therapeutic use
Humans
Immunoglobulin
Immunoglobulins
Lymphocytes
Multiple sclerosis
Multiple Sclerosis - drug therapy
Neutrophils
title Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T03%3A14%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Changes%20in%20lymphocytes,%20neutrophils%20and%20immunoglobulins%20in%20year-1%20cladribine%20treatment%20in%20multiple%20sclerosis&rft.jtitle=Multiple%20sclerosis%20and%20related%20disorders&rft.au=Spiezia,%20Antonio%20Luca&rft.date=2022-01&rft.volume=57&rft.spage=103431&rft.epage=103431&rft.pages=103431-103431&rft.artnum=103431&rft.issn=2211-0348&rft.eissn=2211-0356&rft_id=info:doi/10.1016/j.msard.2021.103431&rft_dat=%3Cproquest_cross%3E2607579022%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2607579022&rft_id=info:pmid/34871857&rft_els_id=S2211034821006970&rfr_iscdi=true